{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T22:58:34Z","timestamp":1775516314887,"version":"3.50.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To determine whether low-density lipoprotein cholesterol (LDL-C) levels, set by the balance of clearance and production, causally contribute to septic shock 28-day mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>We measured LDL-C levels and genotypes in patients with septic shock. Using Genotyping and Genome-Wide Association Study summary statistics from over 150,000 Japanese participants, we genetically predicted pre-infection LDL-C levels. Two-sample Mendelian randomization was used to assess the causal relationship between predicted pre-infection LDL-C levels and 28-day mortality. We analyzed PCSK9 and 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) genotypes to determine if LDL-C clearance or production was the underlying mechanism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Multicenter ICUs in Japan.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Genotyped septic shock patients (<jats:italic toggle=\"yes\">n<\/jats:italic> = 614).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>Predicted pre-infection LDL-C levels were much higher than directly measured LDL-C levels at the onset of septic shock (141 mg\/dL vs. 40 mg\/dL, <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001). Two-sample Mendelian randomization revealed that high predicted pre-infection LDL-C levels were causally associated with increased septic shock 28-day mortality (hazard ratio, 2.78; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.039). <jats:italic toggle=\"yes\">PCSK9<\/jats:italic> genetic variants that increase LDL-C clearance via the LDL receptor (genetically proxied PCSK9 inhibitor treatment) were associated with decreased mortality (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.003) while HMGCR genetic variants that decrease LDL-C production (genetically proxied statin treatment) were not associated with decreased septic shock mortality (indeed the opposite effect was observed, <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.039). The two main genetic variants driving the association between high predicted pre-infection LDL-C levels and increased mortality were in apolipoprotein genes (<jats:italic toggle=\"yes\">ApoB100<\/jats:italic>-rs13306206 and <jats:italic toggle=\"yes\">ApoE<\/jats:italic>-rs7412), apolipoproteins involved in LDL-C binding to the LDL receptor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Low LDL-C clearance explains the causal association between high genetically predicted pre-infection LDL-C levels and increased septic shock mortality. <jats:italic toggle=\"yes\">PCSK9<\/jats:italic>, <jats:italic toggle=\"yes\">ApoB<\/jats:italic>, and <jats:italic toggle=\"yes\">ApoE<\/jats:italic> variants were identified as causal, all related to the LDL receptor or its interaction with LDL-C. Enhancing LDL receptor-mediated clearance of pathogen lipid toxins may improve septic shock outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000006809","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T16:00:58Z","timestamp":1754323258000},"page":"e2033-e2042","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Decreased Clearance of Low-Density Lipoprotein Cholesterol is Causally Associated With Increased Mortality of Septic Shock"],"prefix":"10.1097","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9417-2396","authenticated-orcid":false,"given":"Nozomi","family":"Takahashi","sequence":"first","affiliation":[{"name":"Centre for Heart Lung Innovation, St. Paul\u2019s Hospital, The University of British Columbia, Vancouver, BC, Canada."},{"name":"Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle R.","family":"Campbell","sequence":"additional","affiliation":[{"name":"Centre for Heart Lung Innovation, St. Paul\u2019s Hospital, The University of British Columbia, Vancouver, BC, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taka-aki","family":"Nakada","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith R.","family":"Walley","sequence":"additional","affiliation":[{"name":"Centre for Heart Lung Innovation, St. Paul\u2019s Hospital, The University of British Columbia, Vancouver, BC, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"R1-20251007","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the Global Burden of Disease Study.","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"R2-20251007","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","article-title":"Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019\u2014results from a systematic review and meta-analysis.","volume":"24","author":"Bauer","year":"2020","journal-title":"Crit Care"},{"key":"R3-20251007","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.202105-1197TR","article-title":"The many roles of cholesterol in sepsis: A review.","volume":"205","author":"Hofmaenner","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"R4-20251007","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fphar.2015.00244","article-title":"HDL in sepsis\u2014risk factor and therapeutic approach.","volume":"6","author":"Morin","year":"2015","journal-title":"Front Pharmacol"},{"key":"R5-20251007","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13054-020-02860-3","article-title":"High-density lipoproteins during sepsis: from bench to bedside.","volume":"24","author":"Tanaka","year":"2020","journal-title":"Crit Care"},{"key":"R6-20251007","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/CIRCULATIONAHA.120.048568","article-title":"Inhibition of cholesteryl ester transfer protein preserves high-density lipoprotein cholesterol and improves survival in sepsis.","volume":"143","author":"Trinder","year":"2021","journal-title":"Circulation"},{"key":"R7-20251007","doi-asserted-by":"crossref","first-page":"795460","DOI":"10.3389\/fcell.2021.795460","article-title":"Impact of Sepsis on High-Density Lipoprotein Metabolism.","volume":"9","author":"Reisinger","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R8-20251007","doi-asserted-by":"crossref","first-page":"12965","DOI":"10.3390\/ijms232112965","article-title":"Impact of high-density lipoproteins on sepsis.","volume":"23","author":"De Geest","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R9-20251007","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.2784","article-title":"High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3.","volume":"15","author":"De Nardo","year":"2014","journal-title":"Nat Immunol"},{"key":"R10-20251007","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1164\/rccm.201806-1157OC","article-title":"Cholesteryl ester transfer protein influences high-density lipoprotein levels and survival in sepsis.","volume":"199","author":"Trinder","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-20251007","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13054-015-0832-x","article-title":"Serum levels of apolipoprotein A-I and high-density lipoprotein can predict organ failure in acute pancreatitis.","volume":"19","author":"Peng","year":"2015","journal-title":"Crit Care"},{"key":"R12-20251007","doi-asserted-by":"crossref","first-page":"789298","DOI":"10.1155\/2015\/789298","article-title":"Prognostic implications of serum lipid metabolism over time during Sepsis.","volume":"2015","author":"Lee","year":"2015","journal-title":"Biomed Res Int"},{"key":"R13-20251007","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/CCM.0000000000003551","article-title":"Low low-density lipoprotein levels are associated with, but do not causally contribute to, increased mortality in sepsis.","volume":"47","author":"Walley","year":"2019","journal-title":"Crit Care Med"},{"key":"R14-20251007","doi-asserted-by":"crossref","first-page":"e187223","DOI":"10.1001\/jamanetworkopen.2018.7223","article-title":"Association between low-density lipoprotein cholesterol levels and risk for sepsis among patients admitted to the hospital with infection.","volume":"2","author":"Feng","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R15-20251007","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R16-20251007","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/s41588-024-01913-5","article-title":"Population-specific putative causal variants shape quantitative traits.","volume":"56","author":"Koyama","year":"2024","journal-title":"Nat Genet"},{"key":"R17-20251007","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41588-018-0047-6","article-title":"Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.","volume":"50","author":"Kanai","year":"2018","journal-title":"Nat Genet"},{"key":"R18-20251007","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: A guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"Bmj"},{"key":"R19-20251007","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R20-20251007","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants.","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"key":"R21-20251007","doi-asserted-by":"crossref","first-page":"11122","DOI":"10.1038\/ncomms11122","article-title":"Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA.","volume":"7","author":"Kettunen","year":"2016","journal-title":"Nat Commun"},{"key":"R22-20251007","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00134-018-5328-0","article-title":"Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development: Evidence from Mendelian randomization and mediation analysis.","volume":"44","author":"Reilly","year":"2018","journal-title":"Intensive Care Med"},{"key":"R23-20251007","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1164\/ajrccm.153.2.8564118","article-title":"Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients.","volume":"153","author":"Pittet","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"R24-20251007","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jcrc.2020.01.016","article-title":"Impact of the pre-illness lipid profile on sepsis mortality.","volume":"57","author":"Maile","year":"2020","journal-title":"J Crit Care"},{"key":"R25-20251007","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock.","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"R26-20251007","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","article-title":"Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes.","volume":"375","author":"Ference","year":"2016","journal-title":"N Engl J Med"},{"key":"R27-20251007","doi-asserted-by":"crossref","first-page":"e1003988","DOI":"10.1371\/journal.pmed.1003988","article-title":"Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.","volume":"20","author":"Fang","year":"2023","journal-title":"PLoS Med"},{"key":"R28-20251007","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank.","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"R29-20251007","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jcrc.2016.11.041","article-title":"Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis.","volume":"38","author":"Cirstea","year":"2017","journal-title":"J Crit Care"},{"key":"R30-20251007","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1164\/rccm.201505-0876CI","article-title":"The central role of proprotein convertase subtilisin\/kexin type 9 in septic pathogen lipid transport and clearance.","volume":"192","author":"Walley","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R31-20251007","doi-asserted-by":"crossref","first-page":"258ra143","DOI":"10.1126\/scitranslmed.3008782","article-title":"PCSK9 is a critical regulator of the innate immune response and septic shock outcome.","volume":"6","author":"Walley","year":"2014","journal-title":"Sci Transl Med"},{"key":"R32-20251007","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/hmg\/dds559","article-title":"A common polymorphism in the LDL receptor gene has multiple effects on LDL receptor function.","volume":"22","author":"Gao","year":"2013","journal-title":"Hum Mol Genet"},{"key":"R33-20251007","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: Insights into function.","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem Sci"},{"key":"R34-20251007","doi-asserted-by":"crossref","first-page":"102954","DOI":"10.1016\/j.ebiom.2020.102954","article-title":"Apolipoprotein E (APOE) genotype-associated disease risks: A phenome-wide, registry-based, case-control study utilising the UK Biobank.","volume":"59","author":"Lumsden","year":"2020","journal-title":"EBioMedicine"},{"key":"R35-20251007","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1194\/jlr.P083576","article-title":"Kinetics of plasma apolipoprotein E isoforms by LC-MS\/MS: A pilot study.","volume":"59","author":"Blanchard","year":"2018","journal-title":"J Lipid Res"},{"key":"R36-20251007","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fnagi.2020.00150","article-title":"APOE alleles and diet in brain aging and Alzheimer\u2019s disease.","volume":"12","author":"Yassine","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"R37-20251007","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/01.CCM.0000059724.08290.51","article-title":"Lipoprotein metabolism in patients with severe sepsis.","volume":"31","author":"van Leeuwen","year":"2003","journal-title":"Crit Care Med"},{"key":"R38-20251007","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1097\/01.CCM.0000171183.79525.6B","article-title":"Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis.","volume":"33","author":"Chien","year":"2005","journal-title":"Crit Care Med"},{"key":"R39-20251007","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000442976","article-title":"Increased plasma PCSK9 levels are associated with reduced endotoxin clearance and the development of acute organ failures during sepsis.","volume":"8","author":"Boyd","year":"2016","journal-title":"J Innate Immun"},{"key":"R40-20251007","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ebiom.2018.11.032","article-title":"Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors.","volume":"38","author":"Genga","year":"2018","journal-title":"EBioMedicine"},{"key":"R41-20251007","doi-asserted-by":"crossref","first-page":"e0155030","DOI":"10.1371\/journal.pone.0155030","article-title":"Lipopolysaccharide is cleared from the circulation by hepatocytes via the low density lipoprotein receptor.","volume":"11","author":"Topchiy","year":"2016","journal-title":"PLoS One"},{"key":"R42-20251007","doi-asserted-by":"crossref","first-page":"17483","DOI":"10.1074\/jbc.273.28.17483","article-title":"Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.","volume":"273","author":"Huang","year":"1998","journal-title":"J Biol Chem"},{"key":"R43-20251007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.ATV.8.1.1","article-title":"Apolipoprotein E polymorphism and atherosclerosis.","volume":"8","author":"Davignon","year":"1988","journal-title":"Arteriosclerosis"},{"key":"R44-20251007","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-024-07148-y","article-title":"Genome-wide characterization of circulating metabolic biomarkers.","volume":"628","author":"Karjalainen","year":"2024","journal-title":"Nature"},{"key":"R45-20251007","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1038\/s41467-020-15464-w","article-title":"Ancestry deconvolution and partial polygenic score can improve susceptibility predictions in recently admixed individuals.","volume":"11","author":"Marnetto","year":"2020","journal-title":"Nat Commun"},{"key":"R46-20251007","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1401520","article-title":"Rosuvastatin for sepsis-associated acute respiratory distress syndrome.","volume":"370","author":"Truwit","year":"2014","journal-title":"N Engl J Med"},{"key":"R47-20251007","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13054-023-04387-9","article-title":"Effect of total cholesterol and statin therapy on mortality in ARDS patients: A secondary analysis of the SAILS and HARP-2 trials.","volume":"27","author":"Pienkos","year":"2023","journal-title":"Crit Care"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:00:42Z","timestamp":1759845642000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000006809","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]}}}